379 Results for "

PPAR Agonist

" in MedChemExpress (MCE) Product Catalog:
Products (379)

379 Results for "PPAR Agonist" in MCE Product Catalog:

  • Categories Recommended:
    More
197
197 Publications Verification
Cat. No.: HY-17386A
CAS No.: 302543-62-0
Synonyms: BRL 49653 hydrochloride
Rosiglitazone (BRL 49653) hydrochloride is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone hydrochloride is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone hydrochloride can be used in the research of obesity and diabetes, senescence, ovarian cancer .
loading...
    loading...
197
197 Publications Verification
Cat. No.: HY-17386
CAS No.: 122320-73-4
Synonyms: BRL 49653
Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM), with blood-brain barrier permeability. Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer .
loading...
    loading...
194
194 Cited Publications
Cat. No.: HY-17386B
CAS No.: 316371-84-3
Synonyms: BRL 49653 potassium
Rosiglitazone (BRL 49653) potassium is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone potassium is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone potassium can be used in the research of obesity and diabetes, senescence, ovarian cancer .
loading...
    loading...
150
150 Cited Publications
Cat. No.: HY-14649
CAS No.: 302-79-4
Purity:  99.81%
Synonyms: Vitamin A acid; all-trans-Retinoic acid; ATRA
Retinoic acid is a metabolite of vitamin A that plays important roles in cell growth, differentiation, and organogenesis. Retinoic acid is a natural agonist of RAR nuclear receptors, with IC50s of 14 nM for RARα/β/γ. Retinoic acid bind to PPARβ/δ with Kd of 17 nM. Retinoic acid acts as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha.
loading...
    loading...
53
53 Cited Publications
Cat. No.: HY-14601
CAS No.: 112529-15-4
Purity:  99.97%
Synonyms: U 72107A; AD 4833
Target:  

PPAR Ferroptosis

Research Areas:  

Metabolic Disease Cancer

Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.
loading...
    loading...
53
53 Cited Publications
Cat. No.: HY-13956
CAS No.: 111025-46-8
Purity:  99.89%
Synonyms: U 72107
Target:  

PPAR Ferroptosis

Research Areas:  

Metabolic Disease Cancer

Pioglitazone (U 72107) is an orally active and selective PPARγ (peroxisome proliferator-activated receptor) agonist with high affinity binding to the PPARγ ligand-binding domain with EC50 of 0.93 and 0.99 μM for human and mouse PPARγ, respectively. Pioglitazone can be used in diabetes research .
loading...
    loading...
43
43 Cited Publications
Cat. No.: HY-15027
CAS No.: 89-57-6
Purity:  99.97%
Synonyms: Mesalamine; 5-ASA; Mesalazine
5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).
loading...
    loading...
38
38 Cited Publications
Cat. No.: HY-16995
CAS No.: 50892-23-4
Synonyms: Wy-14643
Target:  

PPAR

Pirinixic acid (Wy-14643) is a potent agonist of PPARα, with EC50s of 0.63 μM, 32 μM for murine PPARα and PPARγ, and 5.0 μM, 60 μM, 35 μM for human PPARα, PPARγ and PPARδ, respectively.
loading...
    loading...
36
36 Cited Publications
Cat. No.: HY-50935
CAS No.: 97322-87-7
Synonyms: CS-045
Research Areas:  

Metabolic Disease Cancer

Troglitazone is an orally active PPARγ agonist, with EC50s of 550 nM and 780 nM for human and murine PPARγ receptor, respectively. Troglitazone has anticancer activity, prevents and inhibits the development of type 2 diabetes.
loading...
    loading...
36
36 Cited Publications
Cat. No.: HY-17356
CAS No.: 49562-28-9
Research Areas:  

Cardiovascular Disease Cancer

Fenofibrate is a selective PPARα agonist with an EC50 of 30 μM. Fenofibrate also inhibits human cytochrome P450 isoforms, with IC50s of 0.2, 0.7, 9.7, 4.8 and 142.1 μM for CYP2C19, CYP2B6, CYP2C9, CYP2C8, and CYP3A4, respectively.
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-10838
CAS No.: 317318-70-0
Purity:  99.27%
Synonyms: GW 1516; GSK-516
Target:  

PPAR Autophagy

Research Areas:  

Metabolic Disease Cancer

GW 501516 (GW 1516) is a PPARδ agonist with an EC50 of 1.1 nM .
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-13861
CAS No.: 265129-71-3
Purity:  99.45%
Target:  

PPAR

Research Areas:  

Cardiovascular Disease

GW7647 is a potent PPARα agonist, with EC50s of 6 nM, 1.1 μM, and 6.2 μM for human PPARα, PPARγ and PPARδ, respectively.
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-13928
CAS No.: 317318-84-6
Purity:  99.94%
Synonyms: GW610742
GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ in binding assay, and EC50s of 1 nM, 1.1 μM and 2 μM for human PPARδ, PPARα, and PPARγ, respectively.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-16737
CAS No.: 923978-27-2
Synonyms: GFT505
Target:  

PPAR

Elafibranor (GFT505) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively. Elafibranor can be used for the study of primary biliary cholangitis .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-B0637
CAS No.: 41859-67-0
Synonyms: BM15075
Target:  

PPAR

Bezafibrate is an agonist of PPAR, with EC50s of 50 μM, 60 μM, 20 μM for human PPARα, PPARγ and PPARδ, and 90 μM, 55 μM, 110 μM for murine PPARα, PPARγ and PPARδ, respectively; Bezafibrate is used as an hypolipidemic agent.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-15655
CAS No.: 196808-24-9
Purity:  99.93%
Target:  

PPAR

GW 1929 is an orally active peroxisome proliferator-activated receptor-γ (PPARγ) agonist with a pKi of 8.84 for human PPAR-γ, and pEC50s of 8.56 and 8.27 for human PPAR-γ and murine PPAR-γ, respectively. GW 1929 (hydrochloride) has antidiabetic efficacy and neuroprotective potential .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-17618
CAS No.: 848259-27-8
Synonyms: (R)-K-13675
Pemafibrate is a highly selective PPARα agonist, with an EC50 of 1 nM.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-19937
CAS No.: 495399-09-2
Target:  

PPAR

Research Areas:  

Metabolic Disease

Saroglitazar is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity with EC50 values of 0.65 pM and 3 nM in HepG2 cells, respectively.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-19937A
CAS No.: 1639792-20-3
Target:  

PPAR

Research Areas:  

Metabolic Disease

Saroglitazar magnesium is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity with EC50 values of 0.65 pM and 3 nM in HepG2 cells, respectively.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-N0234
CAS No.: 19879-30-2
Synonyms: 7-O-Methylbavachin; Bavachinin A
Bavachinin is agonist of pan-peroxisome proliferator-activated receptor (PPAR), with the IC50 value of 21.043 μM, 12.819 μM, and 0.622 μM to PPAR-α, RRAR-β/δ, and PPAR-γ, respectively. Bavachinin is an inhibitor of HIF-1α. Bavachinin exhibits antitumor activity against non-small cell lung cancer by targeting RRAR-γ. Bavachinin is a natural compound with anti-inflammatory and anti-angiogenic activities. Bavachinin has orally bioactivity. .
loading...
    loading...